Within healthcare, Perry is bullish on generic-drug makers like EonLabs (nasdaq: ELAB - news - people ), Barr Laboratories (nyse: BRL - news - people ), Teva Pharmaceutical (nasdaq: TEVA - news - people ), Lannett (nyse: LCI - news - people ) and Perrigo (nasdaq: PRGO - news - people ).